Press Releases Ypsomed Group
Burgdorf – Company has strengthened and enhanced its market position in the fast-growing US needle business.
Ypsomed has signed a supply agreement for insulin pen needles with LifeScan, Inc., the leading maker of blood glucose monitoring systems in the US. As a result, the company has strengthened and enhanced its market position in the fast-growing US needle business. With this agreement, pen needle production in Solothurn has been upgraded with an expanded production line.
